$26.54
0.471.8%
Last update: Nov 6, 5:48 PM
Stoke Therapeutics Inc
STOKNASDAQ
Stoke Therapeutics (STOK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.91 | $-0.78 | $-0.81 | $-0.81 |
| Actual | $-1.08 | $-0.93 | $-0.79 | $-0.97 |
| Surprise | -18.7% | -19.2% | +2.47% | -19.8% |
| Revenue | ||||
| Estimate | $8.2M | $5.4M | $5.2M | $5.2M |
| Actual | $11.3M | $9.3M | $6.2M | $1.4M |
| Surprise | +37.2% | +73.2% | +20.9% | -72.8% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.18 | $-1.11 | $-1.02 | $-0.91 |
| Revenue | ||||
| Consensus | $7.8M | $7.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $-1.08 | $-0.91 | -18.7 % |
| Q2 | Aug 3, 2026 | $-0.93 | $-0.78 | -19.2 % |
| Q1 | May 7, 2026 | $-0.79 | $-0.81 | 2.47 % |
| Q4 | Mar 16, 2026 | $-0.97 | $-0.81 | -19.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $11.26M | $8.20M | 37.2 % |
| Q2 | Aug 3, 2026 | $9.32M | $5.38M | 73.2 % |
| Q1 | May 7, 2026 | $6.23M | $5.15M | 20.9 % |
| Q4 | Mar 16, 2026 | $1.40M | $5.15M | -72.8 % |
